These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 17509484)

  • 41. Apolipoprotein E ε4 allele and malondialdehyde level are independent risk factors for Alzheimer's disease.
    López-Riquelme N; Alom-Poveda J; Viciano-Morote N; Llinares-Ibor I; Tormo-Díaz C
    SAGE Open Med; 2016; 4():2050312115626731. PubMed ID: 26835020
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Non-replication of an association of Apolipoprotein E2 with sinistrality.
    Piper BJ; Yasen AL; Taylor AE; Ruiz JR; Gaynor JW; Dayger CA; Gonzalez-Gross M; Kwon OD; Nilsson LG; Day IN; Raber J; Miller JK
    Laterality; 2013; 18(2):251-61. PubMed ID: 22721421
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of apolipoprotein E gene polymorphism on the intracellular Ca
    Wu H; Zhou S; Zhao H; Wang Y; Chen X; Sun X
    Exp Ther Med; 2018 Feb; 15(2):1417-1423. PubMed ID: 29434726
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The effect of apoprotein E gene polymorphism on neurocognitive functions of children with CHD.
    Bedir Demirdag T; Gucuyener K; Soysal AS; Guntekin Ergun S; Ozturk Z; Ergun MA; Tunaoğlu S
    Cardiol Young; 2023 Sep; 33(9):1556-1560. PubMed ID: 36047305
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The impact of magnetic resonance spectroscopy in elucidating the role of apolipoprotein E ε4 in preclinical Alzheimer's disease.
    Stanley JA
    Biol Psychiatry; 2014 May; 75(9):672-3. PubMed ID: 24731694
    [No Abstract]   [Full Text] [Related]  

  • 46. A non-invasive, rapid method to genotype late-onset Alzheimer's disease-related apolipoprotein E gene polymorphisms.
    Yi L; Wu T; Luo W; Zhou W; Wu J
    Neural Regen Res; 2014 Jan; 9(1):69-75. PubMed ID: 25206745
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Reply to: the impact of magnetic resonance spectroscopy in elucidating the role of apolipoprotein E ε4 in preclinical Alzheimer's disease.
    Gomar JJ; Kingsley PB; Uluğ AM; Conejero-Goldberg C; Barker P; Goldberg TE
    Biol Psychiatry; 2015 Apr; 77(8):e41-2. PubMed ID: 25152433
    [No Abstract]   [Full Text] [Related]  

  • 48. A data-driven model of biomarker changes in sporadic Alzheimer's disease.
    Young AL; Oxtoby NP; Daga P; Cash DM; Fox NC; Ourselin S; Schott JM; Alexander DC;
    Brain; 2014 Sep; 137(Pt 9):2564-77. PubMed ID: 25012224
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Patterns of subregional mesiotemporal disease progression in temporal lobe epilepsy.
    Bernhardt BC; Kim H; Bernasconi N
    Neurology; 2013 Nov; 81(21):1840-7. PubMed ID: 24142475
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Selective disruption of sociocognitive structural brain networks in autism and alexithymia.
    Bernhardt BC; Valk SL; Silani G; Bird G; Frith U; Singer T
    Cereb Cortex; 2014 Dec; 24(12):3258-67. PubMed ID: 23863687
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The autism brain imaging data exchange: towards a large-scale evaluation of the intrinsic brain architecture in autism.
    Di Martino A; Yan CG; Li Q; Denio E; Castellanos FX; Alaerts K; Anderson JS; Assaf M; Bookheimer SY; Dapretto M; Deen B; Delmonte S; Dinstein I; Ertl-Wagner B; Fair DA; Gallagher L; Kennedy DP; Keown CL; Keysers C; Lainhart JE; Lord C; Luna B; Menon V; Minshew NJ; Monk CS; Mueller S; Müller RA; Nebel MB; Nigg JT; O'Hearn K; Pelphrey KA; Peltier SJ; Rudie JD; Sunaert S; Thioux M; Tyszka JM; Uddin LQ; Verhoeven JS; Wenderoth N; Wiggins JL; Mostofsky SH; Milham MP
    Mol Psychiatry; 2014 Jun; 19(6):659-67. PubMed ID: 23774715
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Temporal lobe epilepsy is a progressive neurologic disorder: Time means neurons!
    Cascino GD
    Neurology; 2009 May; 72(20):1718-9. PubMed ID: 19321843
    [No Abstract]   [Full Text] [Related]  

  • 53. Distinct patterns of brain activity in young carriers of the APOE-epsilon4 allele.
    Filippini N; MacIntosh BJ; Hough MG; Goodwin GM; Frisoni GB; Smith SM; Matthews PM; Beckmann CF; Mackay CE
    Proc Natl Acad Sci U S A; 2009 Apr; 106(17):7209-14. PubMed ID: 19357304
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Brain differences in infants at differential genetic risk for late-onset Alzheimer disease: a cross-sectional imaging study.
    Dean DC; Jerskey BA; Chen K; Protas H; Thiyyagura P; Roontiva A; O'Muircheartaigh J; Dirks H; Waskiewicz N; Lehman K; Siniard AL; Turk MN; Hua X; Madsen SK; Thompson PM; Fleisher AS; Huentelman MJ; Deoni SC; Reiman EM
    JAMA Neurol; 2014 Jan; 71(1):11-22. PubMed ID: 24276092
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dissecting the gene dose-effects of the APOE ε4 and ε2 alleles on hippocampal volumes in aging and Alzheimer's disease.
    Hostage CA; Roy Choudhury K; Doraiswamy PM; Petrella JR;
    PLoS One; 2013; 8(2):e54483. PubMed ID: 23405083
    [TBL] [Abstract][Full Text] [Related]  

  • 56. MRI of hippocampal volume loss in early Alzheimer's disease in relation to ApoE genotype and biomarkers.
    Schuff N; Woerner N; Boreta L; Kornfield T; Shaw LM; Trojanowski JQ; Thompson PM; Jack CR; Weiner MW;
    Brain; 2009 Apr; 132(Pt 4):1067-77. PubMed ID: 19251758
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of APOE2 and APOE4 on brain microstructure in older adults: modification by age, sex, and cognitive status.
    Reas ET; Triebswetter C; Banks SJ; McEvoy LK
    Alzheimers Res Ther; 2024 Jan; 16(1):7. PubMed ID: 38212861
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prediction of misfolded proteins spreading in Alzheimer's disease using machine learning and spreading models.
    Gherardini L; Zajdel A; Pini L; Crimi A
    Cereb Cortex; 2023 Dec; 33(24):11471-11485. PubMed ID: 37833822
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Design and Harmonization Approach for the Multi-Institutional Neurocognitive Discovery Study (MINDS) of Adult Congenital Heart Disease (ACHD) Neuroimaging Ancillary Study: A Technical Note.
    Panigrahy A; Schmithorst V; Ceschin R; Lee V; Beluk N; Wallace J; Wheaton O; Chenevert T; Qiu D; Lee JN; Nencka A; Gagoski B; Berman JI; Yuan W; Macgowan C; Coatsworth J; Fleysher L; Cannistraci C; Sleeper LA; Hoskoppal A; Silversides C; Radhakrishnan R; Markham L; Rhodes JF; Dugan LM; Brown N; Ermis P; Fuller S; Cotts TB; Rodriguez FH; Lindsay I; Beers S; Aizenstein H; Bellinger DC; Newburger JW; Umfleet LG; Cohen S; Zaidi A; Gurvitz M;
    J Cardiovasc Dev Dis; 2023 Sep; 10(9):. PubMed ID: 37754810
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pathway-specific polygenic scores for Alzheimer's disease are associated with changes in brain structure in younger and older adults.
    Harrison JR; Foley SF; Baker E; Bracher-Smith M; Holmans P; Stergiakouli E; Linden DEJ; Caseras X; Jones DK; Escott-Price V
    Brain Commun; 2023; 5(5):fcad229. PubMed ID: 37744023
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.